Evidence map›Paper›PMID 34204465›Full record

ArticleVaccines2021

COVID-19 Vaccine Hesitancy and Its Associated Factors in Japan.

Ryo Okubo, Takashi Yoshioka, Satoko Ohfuji, Takahiro Matsuo, Takahiro Tabuchi

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 2 pooled it
17.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 2 syntheses or guidelines pooled it, 167 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Ryo OkuboDepartment of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan.ORCID 0000-0002-1254-1926
Takashi YoshiokaCenter for Innovative Research for Communities and Clinical Excellence (CiRC2LE), Fukushima Medical University, Fukushima 960-1295, Japan.
Satoko OhfujiDepartment of Public Health, Graduate School of Medicine, Osaka City University, Osaka 545-8585, Japan.ORCID 0000-0003-3239-5249
Takahiro MatsuoDivision of Infectious Diseases, St. Luke's International Hospital, Tokyo 104-8560, Japan.
Takahiro TabuchiCancer Control Center, Osaka International Cancer Institute, Osaka 541-8567, Japan.ORCID 0000-0002-1050-3125
Fukushima Medical University · JPNational Center of Neurology and Psychiatry · JPOsaka City University · JPOsaka International Cancer Institute · JPSt. Luke's International Hospital · JP

Funding

Japan Health Research Promotion Bureau Research Fund 2020-B-09Japan Society for the Promotion of Science 18H03062Japan Society for the Promotion of Science 19K20171Japan Society for the Promotion of Science 19K22788
6 · The paper itself

Abstract

The vaccine confidence index in Japan is one of the lowest worldwide. This study aimed to examine the proportion of COVID-19 vaccine hesitancy in the Japanese population using a larger sample and more robust statistical methods than previously, and to identify factors associated with vaccine hesitancy. We conducted a nationwide, cross-sectional Internet survey on 8-26 February 2021, and calculated the proportion and odds ratios for vaccine hesitancy. Among 23,142 responses analyzed, the proportion of COVID-19 vaccine hesitancy was 11.3% (10.9-11.7%). The proportion was higher among younger respondents and female respondents, and especially among younger female respondents (15.6%) compared with the lowest proportion among older male respondents (4.8%). The most cited reason for not getting vaccinated was concerns about adverse reactions in more than 70% of the respondents. The proportion of COVID-19 vaccine hesitancy in Japan was comparable to that in previous studies overseas, and the proportion among younger respondents was more than double that among older respondents. Factors associated with the hesitancy were female sex, living alone, low socioeconomic status, and presence of severe psychological distress, especially among older respondents. Thus, adequate measures should be taken to ensure that vaccines are delivered to people with these factors.

Indexed as

COVID-19Japanlongitudinal studypsychological distresssocial determinants of healthsocioeconomic statusvaccinevaccine hesitancy

Identifiers

PMID34204465
PMCPMC8234307
OpenAlexW3169186146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.